Glucuronides as Potential Anionic Substrates of Human Cytochrome P450 2C8 (CYP2C8)
Authors:
- Yong MaYMYong Ma
- Yue FuYFYue Fu
- S. Cyrus KhojastehSKS. Cyrus Khojasteh
- Donglu ZhangDZDonglu Zhang
- 27 June 2017
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (21) , 8691-8705
Abstract
Glucuronidation is in general considered as a terminal metabolic step that leads to direct elimination of drugs and generally abolishes their biological activity. However, there is growing evidence to suggest that glucuronides can be ligands of human CYP2C8, making CYP2C8 distinct from the other CYP isoforms. Several classes of glucuronide conjugates, which include acyl glucuronides, ether glucuronides, N-glucuronides, and carbamoyl glucuronides, have been shown to be substrates or time-dependent inhibitors of CYP2C8. Although the structures of CYP2C8-glucuronide complexes have not been determined, the structural features of CYP2C8 active site support its binding to anionic and bulky ligands like glucuronides. As interaction perpetrators with CYP2C8, glucuronides of gemfibrozil and clopidogrel showed marked clinical drug–drug interactions (e.g., with cerivastatin and repaglinide), which are more than expected from the parent drug. This review summarizes glucuronides as CYP2C8 ligands and the active-site structural features of CYP2C8 that allow potential binding to glucuronides.Keywords
This publication has 81 references indexed in Scilit:
- Unusual GlucuronidesDrug Metabolism and Disposition, 2012
- N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferasesXenobiotica, 2011
- Human CYP2C8: Structure, Substrate Specificity, Inhibitor Selectivity, Inducers and PolymorphismsCurrent Drug Metabolism, 2009
- Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotypeClinical Pharmacology & Therapeutics, 2006
- Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolitesEuropean Journal of Pharmaceutical Sciences, 2006
- The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in HumansCurrent Drug Metabolism, 2002
- Analysis of Selective Regions in the Active Sites of Human Cytochromes P450, 2C8, 2C9, 2C18, and 2C19 Homology Models Using GRID/CPCAJournal of Medicinal Chemistry, 2001
- Human UDP-Glucuronosyltransferases: Metabolism, Expression, and DiseaseAnnual Review of Pharmacology and Toxicology, 2000
- Glucuronidation in HumansClinical Pharmacokinetics, 1999
- Conjugation-deconjugation cycling of diflunisal via β-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the ratLife Sciences, 1997